Tracy Zimmermann

Tracy Zimmermann

No open positions remaining

Net worth: - $ as of 31/10/2026

57 year
Health Technology
Consumer Services

Profile

Tracy Zimmermann is Chief Scientific Officer at City Therapeutics, Inc. since 2024.
Formerly, Dr. Zimmermann was Chief Development Officer at Generation Bio Co. from 2020 to 2024 and Senior Director-Research at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Education includes undergraduate studies at Lehigh University and a doctorate from the University of Colorado Boulder.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
16/10/2026 0 ( -.--% ) - $ 31/10/2026

Tracy Zimmermann active positions

CompaniesPositionStart

Former positions of Tracy Zimmermann

CompaniesPositionEnd
GENERATION BIO CO. Corporate Officer/Principal 28/01/2024
ALNYLAM PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/09/2018
See the detail of Tracy Zimmermann's experience

Education of Tracy Zimmermann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Tracy Zimmermann